Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study

BACKGROUND: Anti-factor Xa activity has been suggested as a surrogate parameter for judging the effectiveness of pharmacological thromboprophylaxis with low molecular weight heparins in critically ill patients. However, this practice is not supported by evidence associating low anti-factor Xa activi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dibiasi, Christoph, Gratz, Johannes, Wiegele, Marion, Baierl, Andreas, Schaden, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103187/
https://www.ncbi.nlm.nih.gov/pubmed/35573015
http://dx.doi.org/10.3389/fmed.2022.888451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103187/
https://www.ncbi.nlm.nih.gov/pubmed/35573015
http://dx.doi.org/10.3389/fmed.2022.888451

Ejemplares similares